Class information for:
Level 1: AMPEROZIDE//CLOZAPINE//SAVOXEPINE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
10822 1033 40.5 53%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
76 3       NEUROSCIENCES//DOPAMINE//SEROTONIN 81359
75 2             NUCLEUS ACCUMBENS//DOPAMINE//COCAINE 27976
10822 1                   AMPEROZIDE//CLOZAPINE//SAVOXEPINE 1033

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 AMPEROZIDE authKW 239403 2% 45% 18
2 CLOZAPINE authKW 160815 12% 5% 120
3 SAVOXEPINE authKW 147792 0% 100% 5
4 PAW TEST authKW 131664 1% 64% 7
5 HALOPERIDOL authKW 102071 9% 4% 96
6 DEPOLARIZATION BLOCK authKW 101912 1% 34% 10
7 3 METHOXYTYRAMINE authKW 99888 1% 26% 13
8 JL13 authKW 94585 0% 80% 4
9 MELPERONE authKW 80456 1% 39% 7
10 DEPOLARIZATION INACTIVATION authKW 67173 0% 45% 5

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 12108 62% 0% 644
2 Neurosciences 7516 50% 0% 512
3 Psychiatry 5199 26% 0% 269
4 Behavioral Sciences 704 6% 0% 65
5 Clinical Neurology 199 8% 0% 78
6 Medicine, Research & Experimental 141 6% 0% 57
7 Chemistry, Medicinal 106 4% 0% 39
8 Toxicology 37 3% 0% 27
9 Psychology, Biological 16 1% 0% 6
10 Psychology 5 1% 0% 10

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 1CNS 29558 0% 100% 1
2 BERNARDO LODDO EXPTL BIOL 29558 0% 100% 1
3 FARMACEUT RIUNITE SPA 29558 0% 100% 1
4 FORCHHEIMER BLDG G49 29558 0% 100% 1
5 NEUROCHEM PHARMACOL UNIT 951 E LAFAYETTE 29558 0% 100% 1
6 NEUROENDOCRINOL RADIOIMMUNOL 29558 0% 100% 1
7 NEUROFISIOL QUIM DISC ACIDAD 29558 0% 100% 1
8 NEUROGENERAT UNIT 29558 0% 100% 1
9 NEURORREHABILITAC 29558 0% 100% 1
10 PHARAMACEUT UNIT 29558 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PSYCHOPHARMACOLOGY 21593 9% 1% 94
2 EUROPEAN JOURNAL OF PHARMACOLOGY 8083 9% 0% 88
3 BIOGENIC AMINES 6403 1% 2% 13
4 PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY 4694 3% 1% 28
5 PHARMACOPSYCHIATRY 4235 2% 1% 17
6 PHARMACOLOGY & TOXICOLOGY 4036 2% 1% 18
7 PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 3952 4% 0% 41
8 NEUROPHARMACOLOGY 3822 3% 0% 35
9 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 3042 5% 0% 47
10 JOURNAL OF NEURAL TRANSMISSION-GENERAL SECTION 3001 1% 1% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 AMPEROZIDE 239403 2% 45% 18 Search AMPEROZIDE Search AMPEROZIDE
2 CLOZAPINE 160815 12% 5% 120 Search CLOZAPINE Search CLOZAPINE
3 SAVOXEPINE 147792 0% 100% 5 Search SAVOXEPINE Search SAVOXEPINE
4 PAW TEST 131664 1% 64% 7 Search PAW+TEST Search PAW+TEST
5 HALOPERIDOL 102071 9% 4% 96 Search HALOPERIDOL Search HALOPERIDOL
6 DEPOLARIZATION BLOCK 101912 1% 34% 10 Search DEPOLARIZATION+BLOCK Search DEPOLARIZATION+BLOCK
7 3 METHOXYTYRAMINE 99888 1% 26% 13 Search 3+METHOXYTYRAMINE Search 3+METHOXYTYRAMINE
8 JL13 94585 0% 80% 4 Search JL13 Search JL13
9 MELPERONE 80456 1% 39% 7 Search MELPERONE Search MELPERONE
10 DEPOLARIZATION INACTIVATION 67173 0% 45% 5 Search DEPOLARIZATION+INACTIVATION Search DEPOLARIZATION+INACTIVATION

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ASHBY, CR , WANG, RY , (1996) PHARMACOLOGICAL ACTIONS OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE: A REVIEW.SYNAPSE. VOL. 24. ISSUE 4. P. 349 -394 139 37% 116
2 KINON, BJ , LIEBERMAN, JA , (1996) MECHANISMS OF ACTION OF ATYPICAL ANTIPSYCHOTIC DRUGS: A CRITICAL ANALYSIS.PSYCHOPHARMACOLOGY. VOL. 124. ISSUE 1-2. P. 2-34 107 28% 251
3 WESTERINK, BHC , (2002) CAN ANTIPSYCHOTIC DRUGS BE CLASSIFIED BY THEIR EFFECTS ON A PARTICULAR GROUP OF DOPAMINE NEURONS IN THE BRAIN?.EUROPEAN JOURNAL OF PHARMACOLOGY. VOL. 455. ISSUE 1. P. 1-18 61 48% 28
4 EGAN, MF , CHRAPUSTA, S , KAROUM, F , LIPSKA, BK , WYATT, RJ , (1996) EFFECTS OF CHRONIC NEUROLEPTIC TREATMENT ON DOPAMINE RELEASE: INSIGHTS FROM STUDIES USING 3-METHOXYTYRAMINE.JOURNAL OF NEURAL TRANSMISSION. VOL. 103. ISSUE 7. P. 777-805 62 56% 11
5 NOMIKOS, GG , IURLO, M , ANDERSSON, JL , KIMURA, K , SVENSSON, TH , (1994) SYSTEMIC ADMINISTRATION OF AMPEROZIDE, A NEW ATYPICAL ANTIPSYCHOTIC DRUG, PREFERENTIALLY INCREASES DOPAMINE RELEASE IN THE RAT MEDIAL PREFRONTAL CORTEX.PSYCHOPHARMACOLOGY. VOL. 115. ISSUE 1-2. P. 147-156 48 61% 92
6 MELTZER, HY , (1991) THE MECHANISM OF ACTION OF NOVEL ANTIPSYCHOTIC-DRUGS.SCHIZOPHRENIA BULLETIN. VOL. 17. ISSUE 2. P. 263-287 58 43% 324
7 PORTER, JH , PRUS, AJ , (2009) DISCRIMINATIVE STIMULUS PROPERTIES OF ATYPICAL AND TYPICAL ANTIPSYCHOTIC DRUGS: A REVIEW OF PRECLINICAL STUDIES.PSYCHOPHARMACOLOGY. VOL. 203. ISSUE 2. P. 279-294 37 49% 7
8 ARNT, J , SKARSFELDT, T , (1998) DO NOVEL ANTIPSYCHOTICS HAVE SIMILAR PHARMACOLOGICAL CHARACTERISTICS? A REVIEW OF THE EVIDENCE.NEUROPSYCHOPHARMACOLOGY. VOL. 18. ISSUE 2. P. 63 -101 59 22% 550
9 PHILIBIN, SD , WALENTINY, DM , VUNCK, SA , PRUS, AJ , MELTZER, HY , PORTER, JH , (2009) FURTHER CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC DRUG CLOZAPINE IN C57BL/6 MICE: ROLE OF 5-HT2A SEROTONERGIC AND ALPHA(1) ADRENERGIC ANTAGONISM.PSYCHOPHARMACOLOGY. VOL. 203. ISSUE 2. P. 303-315 30 50% 4
10 HERTEL, P , NOMIKOS, GG , IURLO, M , SVENSSON, TH , (1996) RISPERIDONE: REGIONAL EFFECTS IN VIVO ON RELEASE AND METABOLISM OF DOPAMINE AND SEROTONIN IN THE RAT BRAIN.PSYCHOPHARMACOLOGY. VOL. 124. ISSUE 1-2. P. 74 -86 34 57% 88

Classes with closest relation at Level 1


Rank Class id link
1 17531 VACUOUS CHEWING MOVEMENTS//TARDIVE DYSKINESIA//OROFACIAL DYSKINESIA
2 22984 CHOLINERG NEUROPHARMACOL//PRESYNAPTIC D 2 DOPAMINE RECEPTOR//192 IGG SAPORIN AND P75
3 12327 ARIPIPRAZOLE//BLONANSERIN//CONDITIONED AVOIDANCE RESPONSE
4 2915 SKF 83959//DIHYDREXIDINE//DOPAMINE D 1 LIKE RECEPTOR
5 22258 REMOXIPRIDE//AGONIST ANTAGONIST INTERACTION MODEL//1 2 DIAMINOCYCLOPROPANE
6 15663 HOMOVANILLIC ACID//PHVA//PLASMA HOMOVANILLIC ACID
7 12452 OSU6162//ROXINDOLE//TERGURIDE
8 36405 PHAEOFICEAE//CORNEAL TEMPERATURE//ANTIDOPAMINERGIC TYPE ACTIVITY
9 10720 VENTRAL TEGMENTAL AREA//NEURONAL NETWORKS SECT//SUBSTANTIA NIGRA
10 1348 AMISULPRIDE//ANTIPSYCHOTICS//CLOZAPINE

Go to start page